ArticleCancer discovery2023

Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting.

Chani Stossel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.